Ποια είναι η τιμή για OmniAb, Inc. (OABI)

Η τιμή για OmniAb, Inc. (OABI) είναι $4.48

Ποια είναι η κεφαλαιοποίηση αγοράς για OmniAb, Inc. (OABI)

Η κεφαλαιοποίηση αγοράς για OmniAb, Inc. (OABI) είναι $649.33M

OmniAb, Inc. (OABI) Τιμή και Κεφαλαιοποίηση Αγοράς

OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners to access a broad spectrum of antibody repertoires and advanced screening techniques, thereby facilitating the development of next-generation treatments. Central to the OmniAb platform is the unique biological capability of proprietary genetically engineered animals, such as OmniRat, OmniChicken, and OmniMouse. These animals are modified to produce human-sequence antibodies, simplifying the creation of human therapeutic candidates. Additionally, OmniAb offers specialized technologies like OmniFlic (a transgenic rat) and OmniClic (a transgenic chicken), which address the requirements for bispecific antibody applications via a common light chain method, as well as OmniTaur, which leverages the distinct structural properties of cow antibodies for challenging targets. The company was founded in 2012 and is based in Emeryville, California.

Η τιμή για OABI	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$36,309.40 $649.33M	NVDA	$5.264T	+810,558.71%
$32,428.73 $649.33M	AAPL	$4.701T	+723,917.10%
$28,813.57 $649.33M	GOOG	$4.177T	+643,203.69%
$26,331.88 $649.33M	MSFT	$3.817T	+587,796.51%
$19,771.58 $649.33M	AMZN	$2.866T	+441,328.44%

Η τιμή για OABI

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$36,309.40 $649.33M